These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 7864204

  • 1. Phosphatidylethanolamine and sarcolemmal damage during ischemia or metabolic inhibition of heart myocytes.
    Post JA, Bijvelt JJ, Verkleij AJ.
    Am J Physiol; 1995 Feb; 268(2 Pt 2):H773-80. PubMed ID: 7864204
    [Abstract] [Full Text] [Related]

  • 2. Loss of asymmetric distribution of sarcolemmal phosphatidylethanolamine during simulated ischemia in the isolated neonatal rat cardiomyocyte.
    Musters RJ, Otten E, Biegelmann E, Bijvelt J, Keijzer JJ, Post JA, Op den Kamp JA, Verkleij AJ.
    Circ Res; 1993 Sep; 73(3):514-23. PubMed ID: 8348694
    [Abstract] [Full Text] [Related]

  • 3. Sarcolemmal phosphatidylethanolamine reorganization during simulated ischaemia and reperfusion: reversibility and ATP dependency.
    Musters RJ, Pröbstl-Biegelmann E, van Veen TA, Hoebe KH, Op den Kamp JA, Verkleij AJ, Post JA.
    Mol Membr Biol; 1996 Sep; 13(3):159-64. PubMed ID: 8905644
    [Abstract] [Full Text] [Related]

  • 4. Organization and function of sarcolemmal phospholipids in control and ischemic/reperfused cardiomyocytes.
    Post JA, Verkleij AJ, Langer GA.
    J Mol Cell Cardiol; 1995 Feb; 27(2):749-60. PubMed ID: 7776380
    [Abstract] [Full Text] [Related]

  • 5. Phospholipid reorganization and bilayer destabilization during myocardial ischemia and reperfusion: a hypothesis.
    Post JA, Ruigrok TJ, Verkleij AJ.
    J Mol Cell Cardiol; 1988 Mar; 20 Suppl 2():107-11. PubMed ID: 3411610
    [Abstract] [Full Text] [Related]

  • 6. Redistribution of phosphatidylethanolamine and phosphatidylserine precedes reperfusion-induced apoptosis.
    Maulik N, Kagan VE, Tyurin VA, Das DK.
    Am J Physiol; 1998 Jan; 274(1):H242-8. PubMed ID: 9458873
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effects of myocardial ischemia and nisoldipine pretreatment on the asymmetric distribution of phosphatidylethanolamine in a canine heart sarcolemmal preparation.
    Takahashi K, Kako KJ.
    Biochem Med Metab Biol; 1986 Jun; 35(3):308-21. PubMed ID: 3718762
    [Abstract] [Full Text] [Related]

  • 9. Phospholipid asymmetry in cardiac sarcolemma. Analysis of intact cells and 'gas-dissected' membranes.
    Post JA, Langer GA, Op den Kamp JA, Verkleij AJ.
    Biochim Biophys Acta; 1988 Aug 18; 943(2):256-66. PubMed ID: 3401480
    [Abstract] [Full Text] [Related]

  • 10. pHe, [Ca2+]e, and cell death during metabolic inhibition: role of phospholipase A2 and sarcolemmal phospholipids.
    Post JA, Wang SY, Langer GA.
    Am J Physiol; 1998 Jan 18; 274(1):H18-26. PubMed ID: 9458847
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Aggregation of myocardial sarcolemmal transmembrane proteins is not hindered by an interaction with the cytoskeleton. Possible implications for ischemia and reperfusion.
    Schneijdenberg CT, Verkleij AJ, Post JA.
    J Mol Cell Cardiol; 1995 Oct 18; 27(10):2337-45. PubMed ID: 8576948
    [Abstract] [Full Text] [Related]

  • 14. Plasmalogen content and distribution in the sarcolemma of cultured neonatal rat myocytes.
    Post JA, Verkleij AJ, Roelofsen B, Op de Kamp JA.
    FEBS Lett; 1988 Nov 21; 240(1-2):78-82. PubMed ID: 3192002
    [Abstract] [Full Text] [Related]

  • 15. Effect of osmotic stress on sarcolemmal integrity of isolated cardiomyocytes following transient metabolic inhibition.
    Ruiz-Meana M, García-Dorado D, González MA, Barrabés JA, Soler-Soler J.
    Cardiovasc Res; 1995 Jul 21; 30(1):64-9. PubMed ID: 7553725
    [Abstract] [Full Text] [Related]

  • 16. Uncoupling of increased cellular oxidative stress and myocardial ischemia reperfusion injury by directed sarcolemma stabilization.
    Martindale JJ, Metzger JM.
    J Mol Cell Cardiol; 2014 Feb 21; 67():26-37. PubMed ID: 24362314
    [Abstract] [Full Text] [Related]

  • 17. Pre-treatment with trimetazidine increases sarcolemmal mechanical resistance in reoxygenated myocytes.
    Ruiz-Meana M, Garcia-Dorado D, Juliá M, González MA, Inserte J, Soler-Soler J.
    Cardiovasc Res; 1996 Sep 21; 32(3):587-92. PubMed ID: 8881519
    [Abstract] [Full Text] [Related]

  • 18. Selective turnover of sarcolemmal phospholipids with lethal cardiac myocyte injury.
    Miyazaki Y, Gross RW, Sobel BE, Saffitz JE.
    Am J Physiol; 1990 Aug 21; 259(2 Pt 1):C325-31. PubMed ID: 2382705
    [Abstract] [Full Text] [Related]

  • 19. Preferential hydrolysis of phosphatidylethanolamine in rat ischemic heart homogenates during in vitro incubation.
    Kikuchi-Yanoshita R, Yanoshita R, Kudo I, Arai H, Takamura T, Nomoto K, Inoue K.
    J Biochem; 1993 Jul 21; 114(1):33-8. PubMed ID: 8407872
    [Abstract] [Full Text] [Related]

  • 20. Ischemic loss of sarcolemmal dystrophin and spectrin: correlation with myocardial injury.
    Armstrong SC, Latham CA, Shivell CL, Ganote CE.
    J Mol Cell Cardiol; 2001 Jun 21; 33(6):1165-79. PubMed ID: 11444921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.